Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Market Analysis & Valuation

UpdatedNov 15, 2025
DataAggregated Company Financials
Companies135
  • 7D2.3%
  • 3M-5.8%
  • 1Y-33.2%
  • YTD-29.2%

The market is up 2.3% over the last week, with the Healthcare sector leading the way, up 4.8%. Over the past year the market is down 33%. Earnings are forecast to grow by 4.9% annually.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Danish Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 18 Nov 2025DKK 4.0tDKK 2.0tDKK 261.3b14.5x15.2x2x
Thu, 16 Oct 2025DKK 4.1tDKK 1.9tDKK 287.6b15.1x14.4x2.1x
Sat, 13 Sep 2025DKK 4.0tDKK 1.9tDKK 287.3b15x13.9x2.1x
Mon, 11 Aug 2025DKK 3.9tDKK 1.9tDKK 268.4b15.5x14.5x2.1x
Wed, 09 Jul 2025DKK 4.4tDKK 1.9tDKK 261.8b15.6x17x2.4x
Fri, 06 Jun 2025DKK 4.6tDKK 1.9tDKK 263.2b15.6x17.6x2.5x
Sun, 04 May 2025DKK 4.5tDKK 1.9tDKK 259.1b14.6x17.3x2.4x
Tue, 01 Apr 2025DKK 4.5tDKK 1.9tDKK 260.7b14.4x17.2x2.4x
Thu, 27 Feb 2025DKK 5.4tDKK 1.9tDKK 264.8b14.1x20.6x2.9x
Sat, 25 Jan 2025DKK 5.2tDKK 1.8tDKK 237.7b14.1x22x2.9x
Mon, 23 Dec 2024DKK 5.1tDKK 1.8tDKK 238.2b13.6x21.3x2.8x
Wed, 20 Nov 2024DKK 5.7tDKK 1.8tDKK 236.8b14.1x24.1x3.1x
Fri, 18 Oct 2024DKK 6.2tDKK 1.7tDKK 181.2b15.6x34.5x3.6x
Sun, 15 Sep 2024DKK 6.7tDKK 1.7tDKK 180.1b15.6x37.3x3.9x
Tue, 13 Aug 2024DKK 6.5tDKK 1.7tDKK 182.0b16x35.6x3.7x
Thu, 11 Jul 2024DKK 6.9tDKK 1.7tDKK 184.6b15.4x37.4x4x
Sat, 08 Jun 2024DKK 7.0tDKK 1.7tDKK 184.7b14.8x37.6x4.1x
Mon, 06 May 2024DKK 6.2tDKK 1.7tDKK 183.2b14.7x34.1x3.7x
Wed, 03 Apr 2024DKK 6.4tDKK 1.7tDKK 192.6b14.9x33.1x3.7x
Fri, 01 Mar 2024DKK 6.2tDKK 1.7tDKK 192.4b13.2x32x3.6x
Sun, 28 Jan 2024DKK 5.7tDKK 1.8tDKK 216.8b13.8x26.5x3.2x
Tue, 26 Dec 2023DKK 5.5tDKK 1.8tDKK 216.2b13.4x25.5x3.1x
Thu, 23 Nov 2023DKK 5.4tDKK 1.8tDKK 216.9b13.2x24.9x3x
Sat, 21 Oct 2023DKK 5.2tDKK 1.9tDKK 284.9b12.7x18.4x2.8x
Mon, 18 Sep 2023DKK 5.4tDKK 1.9tDKK 283.6b13.4x19x2.9x
Wed, 16 Aug 2023DKK 5.3tDKK 1.9tDKK 278.6b13.4x19x2.8x
Fri, 14 Jul 2023DKK 5.0tDKK 1.9tDKK 317.9b13.5x15.6x2.6x
Sun, 11 Jun 2023DKK 5.1tDKK 1.9tDKK 325.2b14.3x15.7x2.6x
Tue, 09 May 2023DKK 5.2tDKK 1.9tDKK 312.6b14.2x16.7x2.7x
Thu, 06 Apr 2023DKK 4.9tDKK 1.9tDKK 343.7b14.9x14.2x2.5x
Sat, 04 Mar 2023DKK 4.8tDKK 1.9tDKK 348.8b13.9x13.8x2.5x
Mon, 30 Jan 2023DKK 4.6tDKK 1.9tDKK 354.7b13.8x12.9x2.4x
Wed, 28 Dec 2022DKK 4.6tDKK 1.9tDKK 359.5b14x12.7x2.4x
Fri, 25 Nov 2022DKK 4.4tDKK 1.9tDKK 364.5b13.3x12x2.3x
Price to Earnings Ratio

12x


Total Market Cap: DKK 4.4tTotal Earnings: DKK 364.5bTotal Revenue: DKK 1.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Market Price to Earnings3Y Average 22x202320242025
Current Market PE
  • Investors are pessimistic on the Danish market, indicating that they anticipate earnings will not grow as fast as they have historically.
  • The market is trading at a PE ratio of 15.2x which is lower than its 3-year average PE of 22.0x.
Past Earnings Growth
  • The earnings for Danish listed companies have declined 11% per year over the last three years.
  • Meanwhile revenues have been flat.
  • This means that either the cost of doing business or the level of investment back into businesses is increasing since sales have remained steady while profits have fallen.

Sector Trends

Which sectors have driven the changes within the Danish Market?

DK Market2.34%
Utilities5.44%
Healthcare4.80%
Consumer Staples1.45%
Tech0.63%
Real Estate0.52%
Financials0.40%
Materials0.23%
Telecom0.023%
Industrials-0.82%
Consumer Discretionary-1.04%
Energy-3.45%
Sector PE
  • Investors favour the Tech sector the most for future growth, which is trading close to its 3-year average PE ratio of 51.1x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 59.5% which is higher than its past year's earnings decline of 12.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 60% over the next 5 years.
  • This is better than its past earnings decline of 12% per year.
  • In contrast, the Energy sector is expected to see its earnings decline by 36% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
NOVO B Novo NordiskDKK 312.706.1%
+DKK 80.0b		-55.7%PE13.4xHealthcare
ORSTED ØrstedDKK 131.007.0%
+DKK 11.4b		-65.7%PS2.4xUtilities
ALK B ALK-AbellóDKK 236.0015.3%
+DKK 6.9b		52.8%PE47.4xHealthcare
ZEAL Zealand PharmaDKK 524.4020.4%
+DKK 6.2b		-22.5%PE5.6xHealthcare
GMAB GenmabDKK 1.98k5.3%
+DKK 6.2b		35.0%PE11.9xHealthcare
See more

Market Insights

Header cover image
💸 The Return of Share Buybacks in Tech
Richard Bowman avatar
Richard Bowman
|
|
Some of the biggest names in tech are restarting their buyback programs. By the end of this piece, you’ll see: What’s really driving this new buyback cycle, which companies are using it to create genuine value, and when repurchases are smart capital allocation or financial sleight of hand.
Continue reading
⚠️ Default Distress: What Private Credit Troubles Could Mean for Regional Banks
Last Week

⚠️ Default Distress: What Private Credit Troubles Could Mean for Regional Banks

Latest News

FLS
DKK 400.20
FLSmidth
7D
-14.9%
1Y
7.5%
ZEAL
DKK 524.40
Zealand Pharma
7D
20.4%
1Y
-22.5%

Zealand Pharma A/S (CPH:ZEAL) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 16
Zealand Pharma A/S (CPH:ZEAL) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
NOVO B
DKK 312.70
Novo Nordisk
7D
6.1%
1Y
-55.7%
GMAB
DKK 1,975.50
Genmab
7D
5.3%
1Y
35.0%

GMAB: Future Pipeline Expansion and Merus Acquisition Will Define Performance

Genmab's analyst price target has been raised from approximately DKK 2,017 to DKK 2,058. This reflects analysts' increased confidence in the company's pipeline expansion, notably following the Merus acquisition and upside potential from key assets such as Epkinly.
ALK B
DKK 236.00
ALK-Abelló
7D
15.3%
1Y
52.8%

ALK-Abelló A/S (CPH:ALK B) Just Reported And Analysts Have Been Lifting Their Price Targets

Nov 15
ALK-Abelló A/S (CPH:ALK B) Just Reported And Analysts Have Been Lifting Their Price Targets
COLO B
DKK 574.00
Coloplast
7D
-4.4%
1Y
-35.5%

COLO B: Future Execution In Core Markets Will Drive Share Price Momentum

The analyst consensus price target for Coloplast has modestly decreased. Updated projections reflect cautious sentiment from analysts, who cite modest adjustments to growth and profitability expectations.
DEMANT
DKK 214.00
Demant
7D
-3.6%
1Y
-19.3%

DEMANT: Improved Revenue Outlook Will Drive Earnings Growth Into 2025

Analysts have lowered their price target for Demant from DKK 284.19 to DKK 277.69. This change is due to a slight increase in the discount rate and marginal declines in profit margin projections, partially offset by improved revenue growth expectations.
RBREW
DKK 539.50
Royal Unibrew
7D
7.4%
1Y
4.5%
VWS
DKK 155.70
Vestas Wind Systems
7D
1.1%
1Y
55.2%

VWS: Recent Orders And Sector Shifts Will Shape Medium-Term Prospects

Analysts have increased their fair value estimate for Vestas Wind Systems from DKK 142.17 to DKK 153.50. This change reflects updated expectations for profitability and growth based on recent price target adjustments.
GUBRA
DKK 464.60
Gubra
7D
20.2%
1Y
-21.3%
ORSTED
DKK 131.00
Ørsted
7D
7.0%
1Y
-65.7%
ROCK B
DKK 203.05
Rockwool
7D
-5.1%
1Y
-34.2%
MAERSK B
DKK 12,555.00
A.P. Møller - Mærsk
7D
-1.5%
1Y
4.1%

A.P. Møller - Mærsk A/S Just Beat EPS By 22%: Here's What Analysts Think Will Happen Next

Nov 09
A.P. Møller - Mærsk A/S Just Beat EPS By 22%: Here's What Analysts Think Will Happen Next
PNDORA
DKK 761.80
Pandora
7D
-4.5%
1Y
-30.4%
NSIS B
DKK 409.10
Novozymes
7D
-0.9%
1Y
4.9%
DSV
DKK 1,399.50
DSV
7D
-2.1%
1Y
-5.8%